Brief: Expres2ion Biotech Holding Q1 Operating Income Up At SEK 2.6 Mln
May 16 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* Q1 OPERATING INCOME SEK 2.6 MILLION VERSUS SEK 2.1 MILLION
YEAR
AGO
* Q1 PRE-TAX LOSS SEK 30.3 MILLION VERSUS LOSS SEK 14.8
MILLION
YEAR AGO
* OUR OUTLOOK FOR REMAINDER OF 2023 REMAINS POSITIVE
Source text for Eikon: ID:nWkr3ZWCz5
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations